Dacima Consulting
23
2
2
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
8.7%
2 terminated/withdrawn out of 23 trials
88.9%
+2.4% vs industry average
13%
3 trials in Phase 3/4
0%
0 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
National Tunisian Clinical Registry on CardioVascular Secondary Prevention Clinical
Role: lead
Tunisian Lung Cancer Study
Role: lead
The Prevalence of Prediabetes in Primary Care Medicine in Tunisia
Role: lead
Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism
Role: lead
Tunisian National Registry on Psoriasis
Role: lead
Tunisian Clinical Registry on Chronic Kidney Disease in Hypertensive Patients
Role: lead
The Visceral Adiposity Measurement and Observation Study
Role: collaborator
National Tunisian Registry of Cardiac Implantable Electronic Devices
Role: lead
Prevalence of Chronic Kidney Disease in Tunisian Diabetics
Role: lead
Biologic National Registry
Role: lead
National Tunisian Registry of Valvulopathies (NATURE-VALVE)
Role: lead
Biomarkers and Preeclampsia Outcomes
Role: lead
National Tunisian Registry of Hypertension
Role: lead
National Tunisian Registry of Percutaneous Coronary Intervention
Role: lead
OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 "
Role: collaborator
NATional TUnisian REgistry of Atrial Fibrillation
Role: lead
Screening & Health Education in Barbershop Centers for Hypertension
Role: lead
Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)
Role: collaborator
Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study
Role: collaborator
A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers
Role: collaborator